Estradiol regulates different genes in human breast tumor xenografts compared with the identical cells in culture.

In breast cancers, estrogen receptor (ER) levels are highly correlated with response to endocrine therapies. We sought to define mechanisms of estrogen (E) signaling in a solid breast tumor model using gene expression profiling. ER(+) T47D-Y human breast cancer cells were grown as xenografts in ovariectomized nude mice under four conditions: 1) 17beta-estradiol for 8 wk (E); 2) without E for 8 wk (control); 3) E for 7 wk followed by 1 wk of E withdrawal (Ewd); or 4) E for 8 wk plus tamoxifen for the last week. E-regulated genes were defined as those that differed significantly between control and E and/or between E and Ewd or control and Ewd. These protocols generated 188 in vivo E-regulated genes that showed two major patterns of regulation. Approximately 46% returned to basal states after Ewd (class I genes); 53% did not (class II genes). In addition, more than 70% of class II-regulated genes also failed to reverse in response to tamoxifen. These genes may be interesting for the study of hormone-resistance issues. A subset of in vivo E-regulated genes appears on lists of clinical ER discriminator genes. These may be useful therapeutic targets or markers of E activity. Comparison of in vivo E-regulated genes with those regulated in identical cells in vitro after 6 and 24 h of E treatment demonstrate only 11% overlap. This indicates the extent to which gene expression profiles are uniquely dependent on hormone-treatment times and the cellular microenvironment.

[1]  K. Korach,et al.  Analysis of the Molecular Mechanisms of Human Estrogen Receptors α and β Reveals Differential Specificity in Target Promoter Regulation by Xenoestrogens* , 2002, The Journal of Biological Chemistry.

[2]  N. Normanno,et al.  Estrogen and phorbol esters regulate amphiregulin expression by two separate mechanisms in human breast cancer cell lines. , 1995, Endocrinology.

[3]  T. Yamori,et al.  Development of cDNA microarray for expression profiling of estrogen-responsive genes. , 2002, Journal of molecular endocrinology.

[4]  R. Tibshirani,et al.  Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[5]  Xiaolei Wang,et al.  p38 MAPK-dependent and YY1-mediated chemokine receptors CCR5 and CXCR4 up-regulation in U937 cell line infected by Mycobacterium tuberculosis or Actinobacillus actinomycetemcomitans. , 2005, Biochemical and biophysical research communications.

[6]  Yudong D. He,et al.  A Gene-Expression Signature as a Predictor of Survival in Breast Cancer , 2002 .

[7]  Patricia A. Dyck,et al.  Gene expression profiles with activation of the estrogen receptor alpha-selective estrogen receptor modulator complex in breast cancer cells expressing wild-type estrogen receptor. , 2002, Cancer research.

[8]  C. Clarke,et al.  Expression and hormonal regulation of the Sox4 gene in mouse female reproductive tissues. , 1999, Biology of reproduction.

[9]  Eytan Domany,et al.  Outcome signature genes in breast cancer: is there a unique set? , 2004, Breast Cancer Research.

[10]  H. Handa,et al.  Analysis of temporal changes in the expression of estrogen-regulated genes in the uterus. , 2003, Journal of molecular endocrinology.

[11]  Tatsuhiko Tsunoda,et al.  Expression profiling to predict postoperative prognosis for estrogen receptor‐negative breast cancers by analysis of 25,344 genes on a cDNA microarray , 2004, Cancer science.

[12]  B. Katzenellenbogen,et al.  The quinone reductase gene: a unique estrogen receptor-regulated gene that is activated by antiestrogens. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[13]  J. Rosen,et al.  Persistent changes in gene expression induced by estrogen and progesterone in the rat mammary gland. , 2001, Molecular endocrinology.

[14]  C. Hughes,et al.  Integration of the Non-genomic and Genomic Actions of Estrogen , 2002, The Journal of Biological Chemistry.

[15]  J. Visvader,et al.  The LIM domain gene LMO4 inhibits differentiation of mammary epithelial cells in vitro and is overexpressed in breast cancer , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[16]  K. Horwitz,et al.  Variant T47D human breast cancer cells with high progesterone-receptor levels despite estrogen and antiestrogen resistance , 1982, Cell.

[17]  Christian A. Rees,et al.  Molecular portraits of human breast tumours , 2000, Nature.

[18]  O. Almeida,et al.  Developmental expression profiles and distinct regional estrogen responsiveness suggest a novel role for the steroid receptor coactivator SRC‐1 as a discriminative amplifier of estrogen signaling in the rat brain , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[19]  Adrian V. Lee,et al.  Bisphenol-A and estradiol exert novel gene regulation in human MCF-7 derived breast cancer cells , 2004, Molecular and Cellular Endocrinology.

[20]  S K Das,et al.  Global Gene Expression Analysis to Identify Molecular Markers of Uterine Receptivity and Embryo Implantation* 210 , 2001, The Journal of Biological Chemistry.

[21]  K. Horwitz,et al.  Progesterone receptor variants found in breast cells repress transcription by wild-type receptors , 1998, Breast Cancer Research and Treatment.

[22]  Tonya C. Walser,et al.  The role of chemokines in the biology and therapy of breast cancer. , 2004, Breast disease.

[23]  E. Devilard,et al.  Gene expression profiles of poor-prognosis primary breast cancer correlate with survival. , 2002, Human molecular genetics.

[24]  Barry Komm,et al.  Profiling of estrogen up- and down-regulated gene expression in human breast cancer cells: insights into gene networks and pathways underlying estrogenic control of proliferation and cell phenotype. , 2003, Endocrinology.

[25]  Y. Omoto,et al.  A study of estrogen signaling using DNA microarray in human breast cancer , 2002, Breast cancer.

[26]  R. Eckel,et al.  Retinoid X Receptor γ-Deficient Mice Have Increased Skeletal Muscle Lipoprotein Lipase Activity and Less Weight Gain when Fed a High-Fat Diet , 2004 .

[27]  M. Parker,et al.  Identification of novel oestrogen receptor target genes in human ZR75-1 breast cancer cells by expression profiling. , 2001, Journal of molecular endocrinology.

[28]  W. McGuire,et al.  Nuclear estrogen receptors. Effect of inhibitors on processing and steady state levels. , 1980, The Journal of biological chemistry.

[29]  Sophie,et al.  Integrative analysis of gene expression patterns predicts specific modulations of defined cell functions by estrogen and tamoxifen in MCF7 breast cancer cells. , 2005, Journal of molecular endocrinology.

[30]  K. Coser,et al.  Global analysis of ligand sensitivity of estrogen inducible and suppressible genes in MCF7/BUS breast cancer cells by DNA microarray , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[31]  Yudong D. He,et al.  Gene expression profiling predicts clinical outcome of breast cancer , 2002, Nature.

[32]  R. Fulthorpe,et al.  Identification of estrogen-responsive genes by complementary deoxyribonucleic acid microarray and characterization of a novel early estrogen-induced gene: EEIG1. , 2004, Molecular endocrinology.

[33]  Allen Chong,et al.  Discovery of estrogen receptor α target genes and response elements in breast tumor cells , 2004, Genome Biology.

[34]  R. Weigel,et al.  Differential screening and suppression subtractive hybridization identified genes differentially expressed in an estrogen receptor-positive breast carcinoma cell line. , 1998, Nucleic acids research.

[35]  Lucia Altucci,et al.  A genomic view of estrogen actions in human breast cancer cells by expression profiling of the hormone-responsive transcriptome. , 2004, Journal of molecular endocrinology.

[36]  P. Vihko,et al.  Androgens up-regulate the human prostate-specific antigen messenger ribonucleic acid (mRNA), but down-regulate the prostatic acid phosphatase mRNA in the LNCaP cell line. , 1992, Endocrinology.

[37]  B. Katzenellenbogen,et al.  Regulation of estrogen receptor messenger ribonucleic acid and protein levels in human breast cancer cell lines by sex steroid hormones, their antagonists, and growth factors. , 1989, Molecular endocrinology.

[38]  D. Edwards,et al.  The progesterone antagonist RU486 acquires agonist activity upon stimulation of cAMP signaling pathways. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[39]  J. Frasor,et al.  Selective Estrogen Receptor Modulators , 2004, Cancer Research.

[40]  A. Ferguson-Smith,et al.  DNA methylation in genomic imprinting, development, and disease , 2001, The Journal of pathology.

[41]  W. Muller,et al.  ErbB2 overexpression in mammary cells upregulates VEGF through the core promoter. , 2005, Biochemical and biophysical research communications.

[42]  T. Yamano,et al.  Epigenetic up-regulation of C-C chemokine receptor 7 and C-X-C chemokine receptor 4 expression in melanoma cells. , 2005, Cancer research.

[43]  K. Horwitz,et al.  Progestins initiate a luminal to myoepithelial switch in estrogen-dependent human breast tumors without altering growth. , 2005, Cancer research.

[44]  W. Chin,et al.  Tissue-specific regulation of rat estrogen receptor mRNAs. , 1989, Molecular endocrinology.

[45]  S. Romain,et al.  Clinical relevance of amphiregulin and VEGF in primary breast cancers , 2004, International journal of cancer.

[46]  K. Matsushima,et al.  WISP-2 as a novel estrogen-responsive gene in human breast cancer cells. , 2000, Biochemical and biophysical research communications.

[47]  R. Schiff,et al.  Crosstalk between estrogen receptor and growth factor receptor pathways as a cause for endocrine therapy resistance in breast cancer. , 2005, Clinical Cancer Research.

[48]  J. Simard,et al.  Additive stimulatory action of glucocorticoids and androgens on basal and estrogen-repressed apolipoprotein-D messenger ribonucleic acid levels and secretion in human breast cancer cells. , 1992, Endocrinology.

[49]  Marcel Garcia,et al.  Estrogens and their receptors in breast cancer progression: a dual role in cancer proliferation and invasion. , 2004, Critical reviews in oncology/hematology.

[50]  K. Horwitz,et al.  New T47D breast cancer cell lines for the independent study of progesterone B- and A-receptors: only antiprogestin-occupied B-receptors are switched to transcriptional agonists by cAMP. , 1994, Cancer research.

[51]  M. Macleod,et al.  Effects of estrogen on global gene expression: identification of novel targets of estrogen action. , 2000, Cancer research.

[52]  J. Depasquale,et al.  Upstream regions of the estrogen receptor alpha proximal promoter transcript regulate ER protein expression through a translational mechanism , 2005, Molecular and Cellular Endocrinology.

[53]  R. Spang,et al.  Predicting the clinical status of human breast cancer by using gene expression profiles , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[54]  N. Ing,et al.  Estradiol up-regulates estrogen receptor messenger ribonucleic acid in endometrial carcinoma (Ishikawa) cells by stabilizing the message. , 2002, Journal of molecular endocrinology.

[55]  Melissa C Southey,et al.  Stanniocalcin 2 is an estrogen-responsive gene coexpressed with the estrogen receptor in human breast cancer. , 2002, Cancer research.

[56]  Vladimir B Bajic,et al.  Classifying the estrogen receptor status of breast cancers by expression profiles reveals a poor prognosis subpopulation exhibiting high expression of the ERBB2 receptor. , 2003, Human molecular genetics.

[57]  P. Sismondi,et al.  Molecular identification of ERα‐positive breast cancer cells by the expression profile of an intrinsic set of estrogen regulated genes , 2004, Journal of cellular physiology.

[58]  C K Osborne,et al.  Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[59]  L. Katwa,et al.  Effect of 17β-estradiol on gene expression in lumbar spinal cord following sciatic nerve crush injury in ovariectomized mice , 2003, Brain Research.

[60]  S. Hayashi.  Prediction of hormone sensitivity by DNA microarray. , 2004, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[61]  Carsten O. Peterson,et al.  Estrogen receptor status in breast cancer is associated with remarkably distinct gene expression patterns. , 2001, Cancer research.

[62]  M. Polymeropoulos,et al.  Genes that co-cluster with estrogen receptor alpha in microarray analysis of breast biopsies , 2001, The Pharmacogenomics Journal.

[63]  Brad Saville,et al.  Estrogen regulation of vascular endothelial growth factor gene expression in ZR-75 breast cancer cells through interaction of estrogen receptor α and SP proteins , 2004, Oncogene.

[64]  K. Nelson,et al.  Exposure to diethylstilbestrol during a critical developmental period of the mouse reproductive tract leads to persistent induction of two estrogen-regulated genes. , 1994, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[65]  R. Weigel,et al.  PDZK1 and GREB1 are estrogen-regulated genes expressed in hormone-responsive breast cancer. , 2000, Cancer research.

[66]  W. McGuire,et al.  Correlations between estrogen receptor, progesterone receptor, and patient characteristics in human breast cancer. , 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[67]  A. Riva,et al.  Reproductive effects of dietary soy in female Wistar rats. , 1999, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[68]  Fabio Stossi,et al.  Transcriptional profiling of estrogen-regulated gene expression via estrogen receptor (ER) alpha or ERbeta in human osteosarcoma cells: distinct and common target genes for these receptors. , 2004, Endocrinology.

[69]  T. Wood,et al.  Expression of the insulin-like growth factor binding proteins during postnatal development of the murine mammary gland. , 2004, Endocrinology.

[70]  R. Bachelder,et al.  Vascular endothelial growth factor promotes breast carcinoma invasion in an autocrine manner by regulating the chemokine receptor CXCR4. , 2002, Cancer research.

[71]  K. Horwitz,et al.  Progesterone Receptors A and B Differentially Affect the Growth of Estrogen-Dependent Human Breast Tumor Xenografts , 2003, Breast Cancer Research and Treatment.

[72]  E. Lobenhofer,et al.  Regulation of DNA Replication Fork Genes by 17β-Estradiol , 2002 .

[73]  M. Dowsett,et al.  Time‐related effects of estrogen withdrawal on proliferation‐ and cell death‐related events in MCF‐7 xenografts , 1999, International journal of cancer.

[74]  E. J. Neves,et al.  Gene expression profiles in breast tumors regarding the presence or absence of estrogen and progesterone receptors , 2004, International journal of cancer.

[75]  A. Leutz,et al.  Chromatin remodeling in development and differentiation. , 2001, Current opinion in genetics & development.

[76]  M. Ashburner,et al.  Gene Ontology: tool for the unification of biology , 2000, Nature Genetics.